These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2976252)

  • 41. A novel radioiodinated high affinity ligand for the D2-dopamine receptor. Characterization of its binding in bovine anterior pituitary membranes.
    Amlaiky N; Kilpatrick BF; Caron MG
    FEBS Lett; 1984 Oct; 176(2):436-40. PubMed ID: 6548453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA
    Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
    K B; V T; N P; M M; N M; F A
    Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA; Molina-Holgado E; Dewar KM
    Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    Jarvie KR; Niznik HB; Seeman P
    Mol Pharmacol; 1988 Aug; 34(2):91-7. PubMed ID: 2970586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.
    Ariano MA; Monsma FJ; Barton AC; Kang HC; Haugland RP; Sibley DR
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8570-4. PubMed ID: 2479025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
    Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
    J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.
    Seeman P; Guan HC
    Mol Pharmacol; 1987 Dec; 32(6):760-3. PubMed ID: 2961976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study.
    Barkai AI; Durkin M; Nelson HD
    Brain Res; 1990 Oct; 529(1-2):208-13. PubMed ID: 2149297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical importance of D-1 and D-2 receptors.
    Beaulieu M
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):402-6. PubMed ID: 2960428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological and biochemical evidence for the existence of two categories of dopamine receptor.
    Kebabian JW; Beaulieu M; Itoh Y
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):114-7. PubMed ID: 6324982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of purified D2-dopamine receptor from bovine brain and pituitary gland.
    Chazot PL; Strange PG
    Biochem Soc Trans; 1990 Jun; 18(3):432. PubMed ID: 2142652
    [No Abstract]   [Full Text] [Related]  

  • 56. Dopamine, the dopamine D2 receptor and pituitary tumours.
    Wood DF; Johnston JM; Johnston DG
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):455-66. PubMed ID: 1837503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification of brain D2 dopamine receptor.
    Williamson RA; Worrall S; Chazot PL; Strange PG
    EMBO J; 1988 Dec; 7(13):4129-33. PubMed ID: 3243275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine receptors and brain function.
    Jaber M; Robinson SW; Missale C; Caron MG
    Neuropharmacology; 1996; 35(11):1503-19. PubMed ID: 9025098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of some [N-(2-haloalkyl)amino]tetralin derivatives as potential irreversible labels for bovine anterior pituitary D2 dopamine receptors.
    Hall AW; Taylor RJ; Simmonds SH; Strange PG
    J Med Chem; 1987 Oct; 30(10):1879-87. PubMed ID: 3656361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of D2 dopamine-like receptors from brain and from the pituitary gland.
    Chazot PL; Strange PG
    Neurochem Int; 1992 Sep; 21(2):159-69. PubMed ID: 1303148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.